NASDAQ:ABMD
Abiomed
- Stock
Last Close
381.02
21/12 21:00
Market Cap
17.18B
Beta: -
Volume Today
15.70M
Avg: 1.70M
PE Ratio
126.85
PFCF: 68.83
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '15 | Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | ||
|---|---|---|---|---|---|---|---|---|---|
net income | 113.69M - | 38.15M 66.45% | 52.12M 36.62% | 112.17M 115.23% | 259.02M 130.91% | 203.01M 21.62% | 225.53M 11.09% | 136.50M 39.47% | |
depreciation and amortization | 2.77M - | 3.28M 18.30% | 6.20M 89.26% | 11.01M 77.44% | 14.12M 28.31% | 20.43M 44.68% | 24.10M 17.95% | 28.09M 16.57% | |
deferred income tax | -87.09M - | 22.30M 125.60% | 25.80M 15.73% | 42.62M 65.19% | -7.75M 118.17% | 32.95M 525.47% | 29.38M 10.84% | 2.41M 91.79% | |
stock based compensation | 16.52M - | 29.05M 75.87% | 32.87M 13.12% | 40.35M 22.78% | 54.49M 35.04% | 39.78M 27.00% | 47.01M 18.16% | 52.73M 12.18% | |
change in working capital | -4.72M - | -15.60M 230.23% | 5.33M 134.19% | -18.93M 454.90% | -38.84M 105.21% | 8.03M 120.66% | -17.39M 316.65% | -30.20M 73.68% | |
accounts receivables | -7.97M - | -10.93M 37.14% | -11.55M 5.67% | -15.29M 32.37% | -22.02M 44.04% | 5.55M 125.21% | -12.06M 317.24% | 5.33M 144.24% | |
inventory | -6.97M - | -11.47M 64.68% | -12.28M 7.07% | -15.69M 27.69% | -37.18M 137.03% | -13.24M 64.40% | 2.54M 119.15% | -29.32M 1,256.73% | |
accounts payables | 3.37M - | -2.65M 178.44% | 7.57M 386.01% | 4.41M 41.68% | 7.98M 80.78% | 2.58M 67.64% | 2.63M 1.86% | 641K 75.62% | |
other working capital | 6.84M - | 9.45M 38.11% | 21.60M 128.64% | 7.64M 64.65% | 12.39M 62.22% | 13.13M 6.00% | -10.49M 179.90% | -6.85M 34.72% | |
other non cash items | 2.13M - | -378K 117.75% | -7.20M 1,805.82% | 5.32M 173.86% | -28.85M 642.15% | 10.72M 137.17% | -34.04M 417.52% | 95.85M 381.55% | |
net cash provided by operating activities | 43.29M - | 76.80M 77.40% | 115.12M 49.90% | 192.55M 67.26% | 252.20M 30.98% | 314.92M 24.87% | 274.58M 12.81% | 285.39M 3.94% | |
investments in property plant and equipment | -5.19M - | -15.62M 201.16% | -50.41M 222.68% | -55.86M 10.81% | -44.00M 21.23% | -44.01M 0.00% | -53.38M 21.31% | -35.76M 33.01% | |
acquisitions net | -15.70M - | -52.18M - | -82.82M 58.71% | ||||||
purchases of investments | -100.51M - | -261.73M 160.40% | -281.40M 7.52% | -331.81M 17.91% | -404.34M 21.86% | -632.24M 56.36% | -582.30M 7.90% | -805.92M 38.40% | |
sales maturities of investments | 71.53M - | 219.64M 207.06% | 205.48M 6.45% | 206.91M 0.69% | 331.89M 60.40% | 550.79M 65.96% | 464.52M 15.66% | 543.51M 17.00% | |
other investing activites | |||||||||
net cash used for investing activites | -49.86M - | -57.71M 15.74% | -126.33M 118.91% | -180.76M 43.08% | -116.45M 35.58% | -125.45M 7.73% | -223.34M 78.03% | -380.99M 70.58% | |
debt repayment | -446K - | -517K 15.92% | |||||||
common stock issued | 795K - | 1.14M 42.77% | 1.72M 51.54% | 2.39M 39.19% | 3.05M 27.49% | 5.10M 67.20% | 5.48M 7.37% | 7.23M 32.03% | |
common stock repurchased | -84.88M - | -11.31M 86.68% | |||||||
dividends paid | |||||||||
other financing activites | 8.73M - | 6.03M 30.97% | 2.59M 56.96% | -11.01M 524.76% | -58.83M 434.11% | -37.94M 35.51% | -2.24M 94.11% | -9.44M 322.00% | |
net cash used provided by financing activities | 9.52M - | 7.16M 24.81% | 3.87M 45.99% | -9.14M 336.28% | -55.77M 510.43% | -117.72M 111.05% | -8.07M 93.15% | -2.20M 72.70% | |
effect of forex changes on cash | -1.47M - | -415K 71.67% | -1.84M 343.61% | 1.29M 169.96% | -1.92M 249.15% | -430K 77.62% | -2.80M 550.70% | -2.09M 25.30% | |
net change in cash | 1.49M - | 25.83M 1,639.39% | -9.19M 135.58% | 3.94M 142.81% | 78.05M 1,883.38% | 71.32M 8.62% | 40.37M 43.40% | -99.89M 347.45% | |
cash at beginning of period | 20.92M - | 22.40M 7.10% | 48.23M 115.31% | 39.04M 19.06% | 42.98M 10.08% | 121.02M 181.61% | 192.34M 58.93% | 232.71M 20.99% | |
cash at end of period | 22.40M - | 48.23M 115.31% | 39.04M 19.06% | 42.98M 10.08% | 121.02M 181.61% | 192.34M 58.93% | 232.71M 20.99% | 132.82M 42.93% | |
operating cash flow | 43.29M - | 76.80M 77.40% | 115.12M 49.90% | 192.55M 67.26% | 252.20M 30.98% | 314.92M 24.87% | 274.58M 12.81% | 285.39M 3.94% | |
capital expenditure | -5.19M - | -15.62M 201.16% | -50.41M 222.68% | -55.86M 10.81% | -44.00M 21.23% | -44.01M 0.00% | -53.38M 21.31% | -35.76M 33.01% | |
free cash flow | 38.10M - | 61.17M 60.55% | 64.70M 5.77% | 136.68M 111.25% | 208.19M 52.32% | 270.91M 30.13% | 221.19M 18.35% | 249.63M 12.85% |
All numbers in USD (except ratios and percentages)